R. Camacho

发表

Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors.

T. Silander, D. Katzenstein, Y. Moreau, 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Bayesian network analyses of resistance pathways against efavirenz and nevirapine

D. Katzenstein, R. Shafer, M. Soares, 2008, AIDS.

European recommendations for the clinical use of HIV drug resistance testing: 2011 update.

M. Poljak, F. Ceccherini‐Silberstein, R. Paredes, 2011, AIDS reviews.

Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients

M. Poljak, A. Wensing, K. Korn, 2012, Retrovirology.

Pediatric neurodevelopmental treatment

R. Camacho, Brandon McCauley, Christy Szczech Moser, 2016 .

Estimating an In Vivo Fitness Landscape During Protease and Reverse Transcriptase Treatment from Observed Genetic Evolution to Predict Accumulation of Mutations under Selective Pressure

Yves Moreau, Kristof Theys, Anne-Mieke Vandamme, 2007 .

Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.

Anne-Mieke Vandamme, Stijn Imbrechts, Tulio de Oliveira, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations

P. Libin, K. Theys, A. Vandamme, 2020, Viruses.

Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017

P. Libin, A. Vandamme, R. Camacho, 2020, Viruses.

Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations

Pieter J. K. Libin, P. Libin, K. Theys, 2020, Viruses.

Drivers of HIV-1 transmission: The Portuguese case

Guangdi Li, P. Libin, K. Theys, 2019, bioRxiv.

Drivers of HIV-1 transmission: The Portuguese case

Guangdi Li, P. Libin, K. Theys, 2019, PloS one.

Sub-Epidemics Explain Localized High Prevalence of Reduced Susceptibility to Rilpivirine in Treatment-Naive HIV-1-Infected Patients: Subtype and Geographic Compartmentalization of Baseline Resistance Mutations

K. Theys, A. Vandamme, R. Camacho, 2016, AIDS research and human retroviruses.

Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine.

K. Theys, R. Camacho, A. Vandamme, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Comparative performance of the REGA subtyping tool version 2 versus version 1.

P. Libin, A. Vandamme, R. Camacho, 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Molecular epidemiological analysis of paired pol/env sequences from Portuguese HIV type 1 patients.

R. Camacho, A. Carvalho, A. Abecasis, 2011, AIDS research and human retroviruses.

Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon.

M. Suchard, P. Lemey, A. Vandamme, 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The incidence of multidrug and full class resistance in HIV-1 infected patients is decreasing over time (2001–2006) in Portugal

M. Debruyne, K. Theys, A. Vandamme, 2008, Retrovirology.

EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment

R. Camacho, A. Miners, A. Ustianowski, 2016, PloS one.

Possible Footprints of APOBEC3F and/or Other APOBEC3 Deaminases, but Not APOBEC3G, on HIV-1 from Patients with Acute/Early and Chronic Infections

J. Welch, A. Rambaut, K. Deforche, 2014, Journal of Virology.

A near-full length genotypic assay for HCV1b.

A. Vandamme, S. Van Dooren, F. Nevens, 2014, Journal of virological methods.

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.

R. Kaiser, R. Camacho, K. Van Laethem, 2011, The Journal of antimicrobial chemotherapy.

Tracing the Impact of Public Health Interventions on HIV-1 Transmission in Portugal Using Molecular Epidemiology

P. Lemey, O. Pybus, L. du Plessis, 2019, The Journal of infectious diseases.

Edinburgh Research Explorer Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1

A. Rambaut, R. Camacho, A. Vandamme, 2018 .

HIV2EU: supporting standardized HIV‐2 drug resistance interpretation in Europe

C. Charpentier, R. Kaiser, F. Brun-Vézinet, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola

N. Taveira, R. Camacho, Suzana Zakovic, 2014, PloS one.

Rapid clinical progression to AIDS and death in a persistently seronegative HIV-1 infected heterosexual young man

N. Taveira, R. Camacho, Inês Bártolo, 2009, AIDS.

Use of a New Dual-Antigen Enzyme-Linked Immunosorbent Assay To Detect and Characterize the Human Antibody Response to the Human Immunodeficiency Virus Type 2 Envelope gp125 and gp36 Glycoproteins

N. Taveira, R. Camacho, C. Novo, 2006, Journal of Clinical Microbiology.

Characterization of amino acids Arg, Ser and Thr at position 70 within HIV-1 reverse transcriptase

K. Theys, R. Camacho, K. Van Laethem, 2014, Acta clinica Belgica.

Decreasing population selection rates of resistance mutation K65R over time in HIV-1 patients receiving combination therapy including tenofovir.

K. Theys, R. Camacho, J. Snoeck, 2013, The Journal of antimicrobial chemotherapy.

Assessing transmissibility of HIV-1 drug resistance mutations from treated and from drug-naive individuals

J. Aerts, M. Suchard, K. Theys, 2015, AIDS.

Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings

R. Camacho, M. Prosperi, J. Vercauteren, 2014, BMC Public Health.

Antiretroviral therapy in treatment-naïve patients with HIV infection.

R. Camacho, E. Teófilo, 2011, Current opinion in HIV and AIDS.

Optimal adherence to antiretroviral therapy is critical to prevent HIV dru

R. Camacho, M. Prosperi, J. Vercauteren, 2014 .

Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic.

R. Camacho, J. Martinez, F. Rodriguez, 2000, Journal of the National Medical Association.

Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa

B. Hewlett, A. Vandamme, R. Camacho, 2016, PloS one.

The global spread of HIV-1 subtype B epidemic

M. Poljak, A. Wensing, R. Paredes, 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure.

R. Shafer, P. Libin, K. Theys, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G.

A. Vandamme, R. Camacho, A. Carvalho, 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir.

P. Libin, K. Theys, A. Vandamme, 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.

M. T. Paixão, R. Camacho, A. Palma, 2007, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Updated European Recommendations for the Clinical Use of HIV Drug Resistance Testing

JD Lundgren, N Clumeck, A. D. Luca, 2004, Antiviral therapy.

Clinical Evaluation of Rega 8: An Updated Genotypic Interpretation System That Significantly Predicts HIV-Therapy Response

Rolf Kaiser, Anne-Mieke Vandamme, Stijn Imbrechts, 2013, PloS one.

The Calculated Genetic Barrier for Antiretroviral Drug Resistance Substitutions Is Largely Similar for Different HIV-1 Subtypes

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2006, Journal of acquired immune deficiency syndromes.

Development of HIV drug resistance in a cohort of adults on first-line antiretroviral therapy in Tanzania during the stavudine era

R. Camacho, S. Rhee, E. Lyamuya, 2020, Microbiology Research.

An automated genotyping system for analysis of HIV-1 and other microbial sequences

Tulio de Oliveira, Christopher J. Seebregts, David A. van de Vijver, 2005, Bioinform..

Predictors of Attrition and Immunological Failure in HIV-1 Patients on Highly Active Antiretroviral Therapy from Different Healthcare Settings in Mozambique

N. Taveira, R. Camacho, M. Muñoz-Fernández, 2013, PloS one.

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Huldrych F. Günthard, Tulio de Oliveira, Lynn Morris, 2016 .

Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique

F. Antunes, R. Camacho, E. Valadas, 2015, PloS one.

Impact of HIV-1 Subtype and Antiretroviral Therapy on Protease and Reverse Transcriptase Genotype: Results of a Global Collaboration

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2005, PLoS medicine.

Global Dispersal Pattern of HIV Type 1 Subtype CRF01_AE: A Genetic Trace of Human Mobility Related to Heterosexual Sexual Activities Centralized in Southeast Asia.

M. Poljak, A. Wensing, R. Paredes, 2015, The Journal of infectious diseases.

Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation

Philip L. Tzou, D. Katzenstein, R. Shafer, 2017, PloS one.

Multicenter evaluation of a new 4th generation HIV screening assay Elecsys HIV combi.

J. Bartel, R. Camacho, I. Zahn, 2006, Clinical laboratory.

Antiretroviral Drug Resistance in Human Immunodeficiency Virus Type 2

M. Wainberg, M. Ntemgwa, B. Brenner, 2009, Antimicrobial Agents and Chemotherapy.

HIV-2: A summary of present standard of care and treatment options for HIV-2 infected individuals living in Western Europe.

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Human Immunodeficiency Virus–2 (HIV-2): A Summary of the Present Standard of Care and Treatment Options for Individuals Living with HIV-2 in Western Europe

C. Charpentier, R. Kaiser, J. Rockstroh, 2020, Clinical Infectious Diseases.

HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.

C. Charpentier, R. Kaiser, F. Brun-Vézinet, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen

R. Camacho, A. Abecasis, F. Maltêz, 2014, PloS one.

Transmission of drug-resistance in Europe is characterized by single mutations and revertants

A. Wensing, K. Korn, G. Poggensee, 2006 .

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Klaus Korn, Anne-Mieke Vandamme, Sabine Yerly, 2005, The Journal of infectious diseases.

Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes.

R. Camacho, A. Carvalho, I. Costa, 2013, Journal of virological methods.

Comparison of the COBAS TAQMAN HIV-1 HPS with VERSANT HIV-1 RNA 3.0 assay (bDNA) for plasma RNA quantitation in different HIV-1 subtypes.

R. Camacho, A. Carvalho, A. Abecasis, 2006, Journal of virological methods.

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

O. Pybus, A. Wensing, K. Korn, 2009, Retrovirology.

Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form

Anne-Mieke Vandamme, Andrew Rambaut, Philippe Lemey, 2007, Journal of Virology.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

Anne-Mieke Vandamme, Soo-Yon Rhee, Tommy F. Liu, 2009, PloS one.

Full genome sequence of three isolates of hepatitis C virus subtype 4b from Portugal

L. Stuyver, R. Camacho, H. Vermeiren, 2008, Archives of Virology.

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

M. Suchard, P. Lemey, N. Taveira, 2012, The Journal of general virology.

Transmission of drug-resistant HIV-1 is stabilizing in Europe.

M. Poljak, A. Wensing, K. Korn, 2009, The Journal of infectious diseases.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Klaus Korn, Kristof Theys, Anne-Mieke Vandamme, 2013, Retrovirology.

Origin and Epidemiological History of HIV-1 CRF14_BG

N. Taveira, F. McCutchan, R. Camacho, 2011, PloS one.

Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation

Anne-Mieke Vandamme, A. Vandamme, R. Camacho, 2007, Current opinion in HIV and AIDS.

Investigation of Baseline Susceptibility to Protease Inhibitors in HIV-1 Subtypes C, F, G and Crf02_Ag

Anne-Mieke Vandamme, Koen Deforche, Ricardo Jorge Camacho, 2005, Antiviral therapy.

Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G

Anne-Mieke Vandamme, Koen Deforche, Joke Snoeck, 2005, AIDS.

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group

M. Poljak, R. Paredes, K. Korn, 2014, PloS one.

Cell-Associated Viral Burden Provides Evidence of Ongoing Viral Replication in Aviremic HIV-2-Infected Patients

F. Antunes, R. Camacho, R. Foxall, 2010, Journal of Virology.

Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting. The EuroGUidelines Group for HIV resistance.

Soriano, K. Hertogs, F. Brun-Vézinet, 2001, AIDS.

HIV-1 genetic variants circulation in the North of Angola.

A. Vandamme, D. Paraskevis, R. Camacho, 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Special Aspects of the Treatment of HIV-2-Infected Patients

R. Camacho, 2012, Intervirology.

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

Joachim Büch, Thomas Lengauer, Rolf Kaiser, 2016, Retrovirology.

Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in

R. Kaiser, A. Vandamme, R. Camacho, 2013 .

HIV-1 Subtype Is an Independent Predictor of Reverse Transcriptase Mutation K65R in HIV-1 Patients Treated with Combination Antiretroviral Therapy Including Tenofovir

A. De Luca, M. Zazzi, K. Theys, 2012, Antimicrobial Agents and Chemotherapy.

Resistance pathways of human immunodeficiency virus type 1 against the combination of zidovudine and lamivudine.

P. Libin, K. Theys, K. Deforche, 2010, The Journal of general virology.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Rise and Fall of the RT K65R Incidence in the Portuguese Resistance Database

K. Theys, A. Vandamme, K. Deforche, 2006 .

Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.

M. Soares, A. Vandamme, R. Camacho, 2009, The Journal of antimicrobial chemotherapy.

Discordances between Interpretation Algorithms for Genotypic Resistance to Protease and Reverse Transcriptase Inhibitors of Human Immunodeficiency Virus Are Subtype Dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2006, Antimicrobial Agents and Chemotherapy.

HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes

Lynn Morris, Soo-Yon Rhee, Rami Kantor, 2006, AIDS.

Transmission of HIV-2.

R. Camacho, A. Abecasis, K. Mansinho, 2003, The Lancet. Infectious diseases.

Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay.

A. Berger, R. Camacho, U. Schmitt, 1999, Journal of Virological Methods.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

M. Poljak, A. Wensing, R. Paredes, 2014, BMC Infectious Diseases.

Impact of genetic variation of HIV-1 on drug resistance development

A. Vandamme, R. Camacho, J. Snoeck, 2007 .

RegaDB: community-driven data management and analysis for infectious diseases

Jean Ruelle, Peter M. A. Sloot, Stefan Wesner, 2013, Bioinform..

Modelled in vivo HIV Fitness under drug Selective Pressure and Estimated Genetic Barrier Towards Resistance are Predictive for Virological Response

Yves Moreau, Kristof Theys, Anne-Mieke Vandamme, 2008, Antiviral therapy.

Mutations selected in HIV-2-infected patients failing a regimen including atazanavir.

A. Vandamme, R. Camacho, K. Van Laethem, 2013, The Journal of antimicrobial chemotherapy.

Nucleic acid differences between HIV-1 non-B and B reverse transcriptase and protease sequences at drug resistance positions

Soriano, D. Katzenstein, R. Shafer, 2003 .

L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients

A. Vandamme, R. Camacho, A. Abecasis, 2003 .

Limited cross-border infections in patients newly diagnosed with HIV in Europe

M. Poljak, A. Wensing, R. Paredes, 2013, Retrovirology.

A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

Thomas Lengauer, N. Taveira, R. Kaiser, 2016, Retrovirology.

Differential patterns of postmigration HIV-1 infection acquisition among Portuguese immigrants of different geographical origins

R. Camacho, A. Abecasis, A. Pineda-Peña, 2022, AIDS.

HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G.

A. Vandamme, R. Camacho, K. Van Laethem, 2012, The Journal of antimicrobial chemotherapy.

Different substitutions under drug pressure at protease codon 82 in HIV-1 subtype G compared to subtype B infected individuals including a novel 182M resistance mutation

A. Vandamme, R. Camacho, A. Abecasis, 2005 .

Development of a bioinformatics framework for detection of HIV-1 transmission

Kristof Theys, Anne-Mieke Vandamme, Ewout Vanden Eynden, 2015 .

Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors are subtype dependent

Lynn Morris, Anne-Mieke Vandamme, Praphan Phanuphak, 2004 .

Transmission of drug resistance in HIV-2-infected patients

A. Vandamme, R. Camacho, K. Laethem, 2010 .

Analysis of complex HIV-1 intersubtype recombinants using a Bayesian scanning method.

A. Vandamme, K. Deforche, R. Camacho, 2005, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Estimation of an in vivo fitness landscape experienced by HIV-1 under drug selective pressure useful for prediction of drug resistance evolution during treatment

Yves Moreau, Anne-Mieke Vandamme, Ricardo Camacho, 2008, Bioinform..

Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

Domenico Di Carlo, P. A. Bester, R. Shafer, 2022 .

HIV-1 Infection in Cyprus, the Eastern Mediterranean European Frontier: A Densely Sampled Transmission Dynamics Analysis from 1986 to 2012

M. Poljak, A. Wensing, R. Paredes, 2018, Scientific Reports.

The demise of multidrug-resistant HIV-1: the national time trend in Portugal

Kristof Theys, Anne-Mieke Vandamme, Francisco Antunes, 2012, The Journal of antimicrobial chemotherapy.

The global spread of HIV-1 subtype B epidemic

M. Poljak, A. Wensing, R. Paredes, 2016 .

Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form

P. Lemey, A. Rambaut, A. Vandamme, 2007, Journal of Virology.

Genetic subtypes of HIV type 1 circulating in Slovakia.

R. Camacho, D. Staneková, P. Truska, 2010, AIDS research and human retroviruses.

Prevalence of transmitted drug resistance in Europe is largely influenced by the presence of non-B sequences: analysis of 1400 patients from 16 countries: the CATCH-Study

Soriano, A. Wensing, K. Korn, 2003 .

Discordant predictions of residual activity could impact dolutegravir prescription upon raltegravir failure.

Kristof Theys, Pieter Libin, Kristel Van Laethem, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Estimating the Relative Contribution of dNTP Pool Imbalance and APOBEC3G/3F Editing to HIV Evolution In Vivo

Yves Moreau, Anne-Mieke Vandamme, Beth Shapiro, 2007, J. Comput. Biol..

Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe.

R. Kaiser, A. Vandamme, R. Camacho, 2013, The Journal of infectious diseases.

Appearance of a single amino acid insertion at position 33 in HIV type 1 protease under a lopinavir-containing regimen, associated with reduced protease inhibitor susceptibility.

A. Vandamme, A. Molla, G. Magiorkinis, 2011, AIDS research and human retroviruses.

The rise and fall of K65R in a Portuguese HIV-1 Drug Resistance database, despite continuously increasing use of tenofovir.

P. Libin, K. Theys, A. Vandamme, 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

Phylogeographical footprint of colonial history in the global dispersal of human immunodeficiency virus type 2 group A.

M. Suchard, P. Lemey, N. Taveira, 2012, The Journal of general virology.

Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.

Pieter J. K. Libin, A. Vandamme, K. Deforche, 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.